パーソナライズドゲノミクスの世界市場レポート2025年

パーソナライズドゲノミクスの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は15.8％で、169億7,000万米ドルに成長します。今後の成長に寄与する要因としては、オーダーメイド治療への関心の高まり、消費者直接検査（DTC）の普及拡大、予防医療モデルの重視の高まり、ゲノムデータベースや計算ツールへのアクセスの向上、製薬企業とゲノム関連企業との提携強化などが挙げられます。今後の主要動向としては、次世代シーケンス（NGS）法の進展、ゲノム情報の解読におけるAIの利用、ゲノムデータと電子カルテの融合、バイオインフォマティクス技術の進化、ゲノムデータの保存と交換のためのクラウドベースのプラットフォームの拡大などが挙げられます。

慢性疾患や希少疾患の増加は、パーソナライズドゲノミクス市場の成長を促進すると予想されます。慢性疾患は継続的な治療が必要な長期的な疾患であり、希少疾患は頻度が低く、専門的な治療が必要な場合が多いです。不健康な食生活、運動不足、環境リスクへの暴露などのライフスタイル要因が、これらの疾患の増加に大きく寄与しています。パーソナライズドゲノミクスは、個人の遺伝子プロファイルに合わせた治療を行うことで、より正確な診断、標的治療、病状管理の改善を可能にし、慢性疾患や希少疾患の管理に重要な役割を果たしています。例えば、2023年1月、国立生物工学情報センターは、少なくとも1つの慢性疾患を持つ人の数は、2020年の7,152万2,000人から2050年には1億4,266万人へと99.5％増加すると予測していると報告しました。その結果、慢性疾患や希少疾患の負担増がパーソナライズドゲノミクス市場の拡大に寄与しています。

パーソナライズドゲノミクス市場の主要企業は、健康、ウェルネス、疾病予防に関する個別化された洞察を提供するため、パーソナライズドゲノミクスプラットフォームを含む革新的技術の開拓に注力しています。パーソナライズドゲノミクスプラットフォームは、人の遺伝子情報を分析し、カスタマイズ型健康、栄養、治療の推奨を提供するように設計されています。例えば、2024年9月、インドの診断会社Neuberg Diagnostics Private Limitedは、パーソナライズドゲノミクスプラットフォームであるGeniee Decode Your DNAを立ち上げました。このプラットフォームは、健康の最適化、病気の予防、より良い健康結果のための治療のカスタマイズを支援する遺伝子ベース洞察を記載しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、コロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のパーソナライズドゲノミクス：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のパーソナライズドゲノミクス市場：成長率分析
• 世界のパーソナライズドゲノミクス市場の実績：規模と成長、2019～2024年
• 世界のパーソナライズドゲノミクス市場の予測：規模と成長、2024～2029年、2034年
• 世界のパーソナライズドゲノミクス：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界のパーソナライズドゲノミクス市場：検査タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学検査
• 感染症検査
• 神経学的検査
• 心血管検査
• その他の検査タイプ
• 世界のパーソナライズドゲノミクス市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• ポリメラーゼ連鎖反応による検査
• マイクロアレイベースの検査
• シーケンスベースの検査
• その他
• 世界のパーソナライズドゲノミクス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 診断
• 精密医療
• ウェルネス
• 生殖保健
• スポーツ栄養と健康
• ライフスタイル
• その他
• 世界のパーソナライズドゲノミクス市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院とクリニック
• 研究センター
• 製薬とバイオテクノロジー企業
• 診断ラボ
• その他
• 世界のパーソナライズドゲノミクス市場、腫瘍学検査のサブセグメンテーション（検査タイプ別）、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 液体生検
• 腫瘍プロファイリング
• がんリスクの遺伝子検査
• コンパニオン診断
• 世界のパーソナライズドゲノミクス市場、感染症検査のサブセグメンテーション（検査タイプ別）、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 肝炎検査
• COVID-19検査
• 呼吸器感染症検査
• 性感染症検査
• 世界のパーソナライズドゲノミクス市場、神経学的検査のサブセグメンテーション、検査タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アルツハイマー病検査
• ハンチントン病検査
• パーキンソン病検査
• てんかん検査
• 世界のパーソナライズドゲノミクス市場、心血管検査のサブセグメンテーション（検査タイプ別）、タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 心血管疾患の遺伝的リスク
• 不整脈検査
• 脂質パネル検査
• 冠動脈疾患検査
• 世界のパーソナライズドゲノミクス市場、その他の検査タイプのサブセグメンテーション、検査タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 薬理ゲノム学検査
• 遺伝性疾患の遺伝子検査
• 父子鑑定
• 祖先検査

第7章 地域別・国別分析

• 世界のパーソナライズドゲノミクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のパーソナライズドゲノミクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• パーソナライズドゲノミクス市場：競合情勢
• パーソナライズドゲノミクス市場：企業プロファイル
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • BGI Genomics Co. Ltd.
  • Invitae Corporation

第31章 その他の大手企業と革新的企業

• Guardant Health Inc.
• GeneDx LLC
• Ancestry Inc.
• Oxford Nanopore Technologies plc
• Genomic Health Inc.
• 23andMe Holding Co.
• Color Health Inc.
• Helix OpCo LLC
• Personalis Inc.
• Dante Genomics
• Gene By Gene Ltd.
• Veritas Genetics Inc.
• Futura Genetics
• Nebula Genomics Inc.
• Pathway Genomics Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

• パーソナライズドゲノミクス市場、2029年：新たな機会を提供する国
• パーソナライズドゲノミクス市場、2029年：新たな機会を提供するセグメント
• パーソナライズドゲノミクス市場、2029年：成長戦略
  • 市場動向による戦略
  • 競合の戦略

第36章 付録

Personalized genomics refers to the application of an individual's genetic data to customize healthcare, lifestyle guidance, or risk evaluations for diseases, all based on their distinct DNA makeup. It is utilized in areas such as forecasting disease risks, enhancing drug efficacy, and shaping proactive health strategies.

The primary test categories within personalized genomics include oncology testing, infectious disease testing, neurological testing, cardiovascular testing, and various other diagnostic types. Oncology testing encompasses procedures for identifying, diagnosing, and tracking cancer progression through genetic, molecular, and imaging techniques. Methods used in oncology testing comprise polymerase chain reaction (PCR)-based diagnostics, microarray-based analyses, sequencing-based evaluations, and other cutting-edge technologies. These tools support use cases like diagnostics, precision medicine, reproductive health, wellness, sports nutrition, and lifestyle optimization, serving entities such as hospitals, clinics, research bodies, pharmaceutical and biotech firms, diagnostic labs, and more.

The personalized genomics market research report is one of a collection of recent publications from The Business Research Company that delivers comprehensive insights into market statistics for personalized genomics, including global market value, regional distribution, competitive landscape, detailed segmentation, current trends, opportunities, and all other information necessary for success in the industry. This report presents a thorough examination of both present conditions and future projections in the personalized genomics market.

The personalized genomics market size has grown rapidly in recent years. It will grow from $8.15 billion in 2024 to $9.45 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The historical growth can be linked to increased public awareness of genetic health risks, a surge in chronic and hereditary diseases, enhanced use of AI and machine learning in genomics, a rising interest in lifestyle and nutrition-related genomics, and an expanding role of companion diagnostics in oncology and rare conditions.

The personalized genomics market size is expected to see rapid growth in the next few years. It will grow to $16.97 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. Factors contributing to future growth include heightened interest in tailored medical treatments, expanding popularity of direct-to-consumer (DTC) genetic tests, growing emphasis on preventive care models, increased accessibility to genomic databases and computational tools, and strengthened partnerships between pharmaceutical companies and genomic firms. Key upcoming trends include progress in next-generation sequencing (NGS) methods, the use of AI for decoding genomic information, merging of genomic data with electronic medical records, evolution of bioinformatics technologies, and expansion of cloud-based platforms for genomic data storage and exchange.

The increasing prevalence of chronic and rare diseases is anticipated to drive the growth of the personalized genomics market. Chronic diseases are long-term conditions that require continuous care, while rare diseases are infrequent and often demand specialized medical attention. Lifestyle factors such as unhealthy diets, physical inactivity, and exposure to environmental risks contribute significantly to the rise of these diseases. Personalized genomics plays a crucial role in managing chronic and rare diseases by tailoring treatments to an individual's genetic profile, enabling more accurate diagnoses, targeted therapies, and improved condition management. For example, in January 2023, the National Center for Biotechnology Information reported that the number of people with at least one chronic disease is projected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. As a result, the increasing burden of chronic and rare diseases is contributing to the expansion of the personalized genomics market.

Leading companies in the personalized genomics market are focusing on the development of innovative technologies, including personalized genomics platforms, to offer individualized insights into health, wellness, and disease prevention. A personalized genomics platform is designed to analyze a person's genetic information to provide customized health, nutrition, and treatment recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostics company, launched Geniee Decode Your DNA, a personalized genomics platform. This platform delivers genetic-based insights that help optimize health, prevent disease, and customize treatments for better health outcomes.

In February 2022, Labcorp Holdings Inc., a U.S.-based life sciences company, acquired Personal Genome Diagnostics Inc. to strengthen its oncology offerings. The acquisition is intended to broaden access to advanced genomic profiling and liquid biopsy technologies, improving the diagnosis and treatment of cancer through personalized methods. Personal Genome Diagnostics Inc. is a U.S.-based cancer genomics company that focuses on identifying tumor biomarkers to personalize cancer therapies.

Major players in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., and Pathway Genomics Corporation.

North America was the largest region in the personalized genomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the personalized genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized genomics market consists of revenues earned by entities by providing services such as pharmacogenomic services, genetic counseling, and customized fitness plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized genomics market also includes sales of genetic testing kits, health risk assessments, and nutrigenomics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Personalized Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on personalized genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for personalized genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Neurological Testing; Cardiovascular Testing; Other Test Types
• 2) By Technology: Polymerase Chain Reaction-Based Tests; Microarray-Based Tests; Sequencing-Based Tests; Other Technologies
• 3) By Application: Diagnostics; Precision Medicine; Wellness; Reproductive Health; Sports Nutrition And Health; Lifestyle; Other Applications
• 4) By End User: Hospitals And Clinics; Research Centers; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Other End Users
• Subsegments:
• 1) By Oncology Testing: Liquid Biopsy; Tumor Profiling; Genetic Testing For Cancer Risk; Companion Diagnostics
• 2) By Infectious Disease Testing: Hepatitis Testing; COVID-19 Testing; Respiratory Infections Testing; Sexually Transmitted Infections Testing
• 3) By Neurological Testing: Alzheimer's Disease Testing; Huntington's Disease Testing; Parkinson's Disease Testing; Epilepsy Testing
• 4) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases; Arrhythmia Testing; Lipid Panel Testing; Coronary Artery Disease Testing
• 5) By Other Test Types: Pharmacogenomics Testing; Genetic Screening For Inherited Disorders; Paternity Testing; Ancestry Testing
• Companies Mentioned: Thermo Fisher Scientific Inc.; Illumina Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Invitae Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Personalized Genomics Market Characteristics

3. Personalized Genomics Market Trends And Strategies

4. Personalized Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Personalized Genomics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Personalized Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Personalized Genomics Market Growth Rate Analysis
• 5.4. Global Personalized Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Personalized Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Personalized Genomics Total Addressable Market (TAM)

6. Personalized Genomics Market Segmentation

• 6.1. Global Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology Testing
• Infectious Disease Testing
• Neurological Testing
• Cardiovascular Testing
• Other Test Types
• 6.2. Global Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymerase Chain Reaction-Based Tests
• Microarray-Based Tests
• Sequencing-Based Tests
• Other Technologies
• 6.3. Global Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diagnostics
• Precision Medicine
• Wellness
• Reproductive Health
• Sports Nutrition And Health
• Lifestyle
• Other Applications
• 6.4. Global Personalized Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Centers
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Other End Users
• 6.5. Global Personalized Genomics Market, Sub-Segmentation Of Oncology Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Biopsy
• Tumor Profiling
• Genetic Testing for Cancer Risk
• Companion Diagnostics
• 6.6. Global Personalized Genomics Market, Sub-Segmentation Of Infectious Disease Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatitis Testing
• COVID-19 Testing
• Respiratory Infections Testing
• Sexually Transmitted Infections Testing
• 6.7. Global Personalized Genomics Market, Sub-Segmentation Of Neurological Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease Testing
• Huntington's Disease Testing
• Parkinson's Disease Testing
• Epilepsy Testing
• 6.8. Global Personalized Genomics Market, Sub-Segmentation Of Cardiovascular Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Risk for Cardiovascular Diseases
• Arrhythmia Testing
• Lipid Panel Testing
• Coronary Artery Disease Testing
• 6.9. Global Personalized Genomics Market, Sub-Segmentation Of Other Test Types, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacogenomics Testing
• Genetic Screening for Inherited Disorders
• Paternity Testing
• Ancestry Testing

7. Personalized Genomics Market Regional And Country Analysis

• 7.1. Global Personalized Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Personalized Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Personalized Genomics Market

• 8.1. Asia-Pacific Personalized Genomics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Personalized Genomics Market

• 9.1. China Personalized Genomics Market Overview
• 9.2. China Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Personalized Genomics Market

• 10.1. India Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Personalized Genomics Market

• 11.1. Japan Personalized Genomics Market Overview
• 11.2. Japan Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Personalized Genomics Market

• 12.1. Australia Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Personalized Genomics Market

• 13.1. Indonesia Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Personalized Genomics Market

• 14.1. South Korea Personalized Genomics Market Overview
• 14.2. South Korea Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Personalized Genomics Market

• 15.1. Western Europe Personalized Genomics Market Overview
• 15.2. Western Europe Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Personalized Genomics Market

• 16.1. UK Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Personalized Genomics Market

• 17.1. Germany Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Personalized Genomics Market

• 18.1. France Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Personalized Genomics Market

• 19.1. Italy Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Personalized Genomics Market

• 20.1. Spain Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Personalized Genomics Market

• 21.1. Eastern Europe Personalized Genomics Market Overview
• 21.2. Eastern Europe Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Personalized Genomics Market

• 22.1. Russia Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Personalized Genomics Market

• 23.1. North America Personalized Genomics Market Overview
• 23.2. North America Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Personalized Genomics Market

• 24.1. USA Personalized Genomics Market Overview
• 24.2. USA Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Personalized Genomics Market

• 25.1. Canada Personalized Genomics Market Overview
• 25.2. Canada Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Personalized Genomics Market

• 26.1. South America Personalized Genomics Market Overview
• 26.2. South America Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Personalized Genomics Market

• 27.1. Brazil Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Personalized Genomics Market

• 28.1. Middle East Personalized Genomics Market Overview
• 28.2. Middle East Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Personalized Genomics Market

• 29.1. Africa Personalized Genomics Market Overview
• 29.2. Africa Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Personalized Genomics Market Competitive Landscape And Company Profiles

• 30.1. Personalized Genomics Market Competitive Landscape
• 30.2. Personalized Genomics Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Myriad Genetics Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. BGI Genomics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Personalized Genomics Market Other Major And Innovative Companies

• 31.1. Guardant Health Inc.
• 31.2. GeneDx LLC
• 31.3. Ancestry Inc.
• 31.4. Oxford Nanopore Technologies plc
• 31.5. Genomic Health Inc.
• 31.6. 23andMe Holding Co.
• 31.7. Color Health Inc.
• 31.8. Helix OpCo LLC
• 31.9. Personalis Inc.
• 31.10. Dante Genomics
• 31.11. Gene By Gene Ltd.
• 31.12. Veritas Genetics Inc.
• 31.13. Futura Genetics
• 31.14. Nebula Genomics Inc.
• 31.15. Pathway Genomics Corporation

32. Global Personalized Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Personalized Genomics Market

34. Recent Developments In The Personalized Genomics Market

35. Personalized Genomics Market High Potential Countries, Segments and Strategies

• 35.1 Personalized Genomics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Personalized Genomics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Personalized Genomics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer